Alzmenda 10/1 Mg Oral Drops 20 ml

Alzmenda 10/1 Mg Oral Drops 20 ml

Description:

Alzmenda 10/1 mg oral drops 20 ml is a prescription antidementia medicine containing memantine, used in the management of moderate to severe Alzheimer’s disease. Memantine is an N-methyl-D-aspartate (NMDA) receptor antagonist that helps regulate abnormal glutamate activity in the brain, which is associated with memory loss, cognitive decline, and behavioral symptoms in Alzheimer’s disease. This oral drops formulation allows flexible dosing and easier administration, especially for elderly patients who have difficulty swallowing tablets.

Indications:

• Management of moderate to severe Alzheimer’s disease.
• Helps improve or stabilize cognitive function such as memory, attention, and thinking ability in patients with Alzheimer’s dementia.
• May help reduce behavioral and psychological symptoms associated with Alzheimer’s disease, such as confusion, disorientation, and agitation, as assessed by the treating physician.
• Used as part of a comprehensive treatment plan for dementia under medical supervision.

Active Ingredients / Key Components:

• Memantine – 10 mg/g (exact amount of memantine per ml is not specified in the available product information; detailed concentration per ml is unavailable).
• Other excipients/inactive ingredients: Not specified in the available data (full excipient list is unavailable; refer to the package leaflet for complete composition).

Dosage & Administration / How to Use:

• Alzmenda 10/1 mg oral drops must be used exactly as prescribed by the physician. Do not change the dose or stop treatment without medical advice.
• Typical memantine therapy is started at a low dose and gradually increased (titrated) to the maintenance dose as directed by the doctor. The exact dosing schedule for Alzmenda drops should follow the prescribing information and physician’s instructions.
• Shake the bottle gently if instructed by the leaflet, then measure the prescribed number of drops using the dropper provided (if included) or as directed.
• Administer the drops orally. They may be taken with or without food, preferably at the same time each day to help adherence.
• If the drops are mixed with a small amount of water or soft food, consume the entire amount immediately to ensure the full dose is taken.
• If a dose is missed, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed one.
• Use in children and adolescents: Memantine for Alzheimer’s disease is generally intended for adults and elderly patients; use in patients under 18 years is not usually recommended unless specifically directed by a specialist.
• Duration of treatment is long term and depends on clinical response and tolerability. Regular follow-up with the doctor is required to reassess benefit and adjust dose if needed.

Clinical Benefits:

• Helps slow the progression of symptoms in moderate to severe Alzheimer’s disease by modulating abnormal glutamate activity in the brain.
• Supports cognitive function, including memory, orientation, and the ability to perform daily tasks, as evaluated by healthcare professionals.
• May contribute to improved behavioral and psychological symptoms of dementia, such as agitation and confusion, when used as part of a comprehensive care plan.
• Oral drops formulation facilitates easier administration and flexible dosing for elderly patients or those with swallowing difficulties.

Warnings & Contraindications:

• Use only under the supervision of a physician experienced in the diagnosis and treatment of Alzheimer’s disease.
• Contraindicated in patients with known hypersensitivity to memantine or any of the excipients (full excipient list is in the official leaflet).
• Use with caution in patients with a history of seizures, epilepsy, or conditions that increase seizure risk.
• Use with caution in patients with renal impairment; dose adjustment may be required according to kidney function. Severe renal impairment requires strict medical supervision.
• Use with caution in patients with recent myocardial infarction, uncompensated congestive heart failure, or uncontrolled hypertension; regular monitoring may be needed.
• Memantine may interact with other medicines that act on NMDA receptors (e.g., amantadine, ketamine, dextromethorphan) and with certain other drugs; always inform your doctor about all medications and supplements you are taking.
• Consult your doctor before use if pregnant, nursing, taking medications, or have medical conditions such as kidney disease, liver disease, seizure disorders, cardiovascular disease, or uncontrolled hypertension.
• Driving and using machines: Memantine can cause dizziness, drowsiness, or confusion in some patients. If affected, do not drive or operate machinery.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision.
• Keep out of reach of children.

Side Effects:

• Common side effects may include dizziness, headache, constipation, drowsiness, balance problems, or increased blood pressure.
• Less common side effects can include confusion, hallucinations, fatigue, shortness of breath, vomiting, or allergic skin reactions.
• Serious side effects (seek immediate medical attention): signs of severe allergic reaction (rash, itching, swelling of face/lips/tongue, difficulty breathing), seizures, severe confusion or agitation, or sudden changes in blood pressure.
• Not all patients will experience side effects. If any side effect is severe, persistent, or worrying, contact your doctor or pharmacist promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date stated on the package. Store at the temperature conditions indicated in the official leaflet (specific temperature range is not provided in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.); refer to the pack).

Specifications:

• Product type: Prescription antidementia medicine (memantine).
• Form: Oral drops.
• Volume: 20 ml per bottle.
• Active ingredient: Memantine (10 mg/g; exact mg per ml not specified in available data).
• Intended use: Adult and elderly patients with moderate to severe Alzheimer’s disease, under medical supervision.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.